Filtruoti pagal Last updated date SelectPoIkiFrom - To Data Pabaigos data This week Šį mėnesį Last week Praeitą mėnesį Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Rezultatai (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Committee for Orphan Medicinal Products: January 2005 meeting 18 Sausis 2005Press releaseHumanRare diseases Committee for medicinal products for veterinary use: Meeting of 11-12 January 2005 13 Sausis 2005Press releaseVeterinary Important new pharmacokinetic data demonstrating that REYATAZ (atazanavirsulfate) combined with NORVIR (ritonavir) and omeprazole should not be co-administered 22 Gruodis 2004News European Medicines Agency statement on celecoxib 17 Gruodis 2004Press releaseMedicines Management Board finalises its long-term plan and adopts workprogramme and budget for 2005 17 Gruodis 2004Press releaseCorporate European Medicines Agency: Committee for Medicinal Products for Human Use 13-15 December 2004 16 Gruodis 2004Press releaseHumanMedicines European Medicines Agency public statement on valdecoxib and parecoxib sodium. Cardiovascular risks in coronary artery bypass graft surgery and serious adverse skin reactions 15 Gruodis 2004NewsMedicines Committee for medicinal products for veterinary use: Meeting of 7 to 9 December 2004 10 Gruodis 2004Press releaseVeterinary Committee for Orphan Medicinal Products: December 2004 meeting 10 Gruodis 2004Press releaseHumanRare diseases CHMP meeting on Paroxetine and other SSRIs 9 Gruodis 2004Press release 1 … 337 338 339 340 341 Page 341 of 380 342 343 344 345 … 380
Committee for Orphan Medicinal Products: January 2005 meeting 18 Sausis 2005Press releaseHumanRare diseases
Committee for medicinal products for veterinary use: Meeting of 11-12 January 2005 13 Sausis 2005Press releaseVeterinary
Important new pharmacokinetic data demonstrating that REYATAZ (atazanavirsulfate) combined with NORVIR (ritonavir) and omeprazole should not be co-administered 22 Gruodis 2004News
Management Board finalises its long-term plan and adopts workprogramme and budget for 2005 17 Gruodis 2004Press releaseCorporate
European Medicines Agency: Committee for Medicinal Products for Human Use 13-15 December 2004 16 Gruodis 2004Press releaseHumanMedicines
European Medicines Agency public statement on valdecoxib and parecoxib sodium. Cardiovascular risks in coronary artery bypass graft surgery and serious adverse skin reactions 15 Gruodis 2004NewsMedicines
Committee for medicinal products for veterinary use: Meeting of 7 to 9 December 2004 10 Gruodis 2004Press releaseVeterinary
Committee for Orphan Medicinal Products: December 2004 meeting 10 Gruodis 2004Press releaseHumanRare diseases